Glioblastoma Cancer Stem Cells Evade Innate Immune Suppression of Self-Renewal through Reduced TLR4 Expression.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cell Stem Cell

• Publication date

  2017-04-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.stem.2016.12.001PMID 28089910PMCID PMC5822422
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• GlioVis data portal for visualization and analysis of brain tumor expression datasets.

  2017cited by this paper
• TLR4 Signaling via NANOG Cooperates With STAT3 to Activate Twist1 and Promote Formation of Tumor-Initiating Stem-Like Cells in Livers of Mice.

  2016cited by this paper
• Retinoblastoma Binding Protein 4 Modulates Temozolomide Sensitivity in Glioblastoma by Regulating DNA Repair Proteins.

  2016cited by this paper
• Glioma-derived versican promotes tumor expansion via glioma-associated microglial/macrophages Toll-like receptor 2 signaling.

  2015cited by this paper
• Cancer stem cells in glioblastoma

  2015cited by this paper
• CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer

  2015cited by this paper
• Erlotinib protects against LPS-induced Endotoxicity because TLR4 needs EGFR to signal

  2015cited by this paper
• CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012

  2015cited by this paper
• Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells.

  2015cited by this paper
• Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice.

  2015cited by this paper
• Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells.

  2014cited by this paper
• TLR9 is critical for glioma stem cell maintenance and targeting.

  2014cited by this paper
• The Yin and Yang of Toll-like receptors in cancer

  2014cited by this paper
• Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma

  2014cited by this paper
• Toll-like receptor 2 mediates microglia/brain macrophage MT1-MMP expression and glioma expansion.

  2013cited by this paper
• Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells.

  2013cited by this paper
• A tumorigenic MLL-homeobox network in human glioblastoma stem cells.

  2013cited by this paper
• The history of Toll-like receptors — redefining innate immunity

  2013cited by this paper
• Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms

  2013cited by this paper
• The somatic genomic landscape of glioblastoma.

  2013cited by this paper
• A restricted cell population propagates glioblastoma growth following chemotherapy

  2012cited by this paper
• WRAD: enabler of the SET1-family of H3K4 methyltransferases.

  2012cited by this paper
• Cancer stem cells: current status and evolving complexities.

  2012cited by this paper
• Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4.

  2012cited by this paper
• CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.

  2012cited by this paper
• Acidic stress promotes a glioma stem cell phenotype

  2011cited by this paper
• Involvement of TNFα-induced TLR4–NF-κB and TLR4–HIF-1α feed-forward loops in the regulation of inflammatory responses in glioma

  2011cited by this paper
• Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions

  2011cited by this paper
• TLR4 signal transduction pathways neutralize the effect of Fas signals on glioblastoma cell proliferation and migration.

  2011cited by this paper
• Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential

  2011cited by this paper
• Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis.

  2010cited by this paper
• Toll-like receptor (TLR) 7 and TLR8 expression on CD133+ cells in colorectal cancer points to a specific role for inflammation-induced TLRs in tumourigenesis and tumour progression.

  2010cited by this paper
• Cancer esearch cular and Cellular Pathobiology ermal Growth Factor Receptor Expression Identifies ctionally and Molecularly Distinct Tumor-Initiating Cells uman Glioblastoma Multiforme and Is Required R Gliomagenesis

  2010cited by this paper
• TLR2 activation inhibits embryonic neural progenitor cell proliferation

  2010cited by this paper
• TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma.

  2010cited by this paper
• Toll-like receptors in the CNS: implications for neurodegeneration and repair.

  2009cited by this paper
• Embryonic Stem Cells and Mammary Luminal Progenitors Directly Sense and Respond to Microbial Products

  2009cited by this paper
• Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.

  2009cited by this paper
• Toll-like receptors in neurodegeneration.

  2009cited by this paper
• PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells.

  2009cited by this paper
• HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression

  2009cited by this paper
• ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays.

  2009cited by this paper
• Toll-Like Receptor 3 Is a Negative Regulator of Embryonic Neural Progenitor Cell Proliferation

  2008cited by this paper
• Brain Cancer Stem Cells Display Preferential Sensitivity to Akt Inhibition

  2008cited by this paper
• Toll-like receptor 4 restricts retinal progenitor cell proliferation

  2008cited by this paper
• DAMPs, PAMPs and alarmins: all we need to know about danger

  2007cited by this paper
• Toll-like receptors modulate adult hippocampal neurogenesis

  2007cited by this paper
• Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

  2006cited by this paper
• TLR Signaling Tailors Innate Immune Responses in Human Microglia and Astrocytes1

  2005cited by this paper
• AP-1 subunits: quarrel and harmony among siblings

  2004cited by this paper
• Identification of human brain tumour initiating cells

  2004cited by this paper
• Intratumoral Injection of Lipopolysaccharide Causes Regression of Subcutaneously Implanted Mouse Glioblastoma Multiforme

  2001cited by this paper

• Biomedical engineering targeting cancer stem cells to reinforce cancer therapy

  2025cites this paper
• TIR domain proteins: regulatory mechanisms in the tumor immune microenvironment, clinical translation strategies, and prospects for precision therapy applications

  2025cites this paper
• Tumor Microenvironment in Glioblastoma: The Central Role of the Hypoxic-Necrotic Core.

  2025cites this paper
• Radiation-induced Glioblastoma Stem Cell-mediated T Cell Exhaustion via EGR1-Gal3-LAG3 Axis in Glioblastoma.

  2025cites this paper
• Mesenchymal stem cell derived extracellular vesicles reverses neural aging via OSKM modulation

  2025cites this paper
• Microbiome-mediated regulation of chemoradiotherapy response

  2025cites this paper
• The PCNA inhibitor AOH1996 suppresses cancer stemness and enhances anti-PD1 immunotherapy in squamous cell carcinoma

  2025influential citation
• Impact of gastrointestinal dysbiosis on tryptophan metabolism and neurological cancer progression

  2025cites this paper
• Harnessing the innate immune system for glioblastoma therapeutics.

  2025cites this paper
• Epigenetic regulation of cancer stemness

  2025cites this paper
• How stem cells respond to infection, inflammation and ageing

  2025cites this paper
• Design of a novel multiepitope vaccine against glioblastoma by in silico approaches

  2025cites this paper
• An Asynchronous-Regulated Nanosheet Cascade Amplifies Sonodynamic-Triggered Self-Enhanced DNA Damage for Intensive Tumor Immunotherapy.

  2025cites this paper
• Stress-induced pro-inflammatory glioblastoma stem cells secrete TNFAIP6 to enhance tumor growth and induce suppressive macrophages.

  2025cites this paper
• Single-Cell and Spatial Transcriptomics Explore Purine Metabolism–Related Prognostic Risk Model and Tumor Immune Microenvironment Modulation in Ovarian Cancer

  2025cites this paper
• Kinin B1 Receptor Agonist Enhances Blood-Brain Barrier Permeability in Healthy and Glioblastoma Environments

  2025cites this paper
• Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance

  2025cites this paper
• Seasonal influenza vaccines differentially activate and modulate toll-like receptor expression within the tumor microenvironment

  2024cites this paper
• Bioinformatics Analysis of Metabolic Signaling Pathways in Glioblastoma Cancer Stem Cells

  2024cites this paper
• Infiltrating plasma cells maintain glioblastoma stem cells through IgG-Tumor binding.

  2024cites this paper
• Everything you ever wanted to know about cancer stem cells in neuroendocrine neoplasms but were afraid to ask

  2024cites this paper
• Stemness in solid malignancies: coping with immune attack

  2024cites this paper
• Optimization of SOX2 Expression for Enhanced Glioblastoma Stem Cell Virotherapy

  2024cites this paper
• Comprehensive exploration on the role of base excision repair genes in modulating immune infiltration in low-grade glioma.

  2024cites this paper
• TBK1 is paradoxical in tumor development: a focus on the pathway mediating IFN-I expression

  2024cites this paper
• Connexin 43 drives glioblastoma cancer stem cell phenotypes through a WNK lysine-deficient protein kinase 1-c-MYC signaling axis

  2024cites this paper
• Evaluation of secretome biomarkers in glioblastoma cancer stem cells: A bioinformatics analysis

  2024cites this paper
• Modulatory effects of cancer stem cell-derived extracellular vesicles on the tumor immune microenvironment

  2024cites this paper
• Hallmarks of cancer stemness.

  2024cites this paper
• Glioblastoma stem cell metabolism and immunity

  2024cites this paper
• Shedding light on function of long non-coding RNAs (lncRNAs) in glioblastoma

  2024cites this paper
• Regulated cell death in glioma: promising targets for natural small-molecule compounds

  2024cites this paper
• The tumour ecology of quiescence: niches across scales of complexity.

  2023cites this paper
• Identification of glioblastoma stem cell-associated lncRNAs using single-cell RNA sequencing datasets

  2023cites this paper
• Neuronal differentiation drives the antitumor activity of mitogen-activated protein kinase kinase (MEK) inhibition in glioblastoma

  2023cites this paper
• A TOX-ic axis of epigenetic stem cell maintenance and chemoresistance in colon cancer

  2023cites this paper
• Emerging Role of Glioma Stem Cells in Mechanisms of Therapy Resistance

  2023cites this paper
• The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer

  2023cites this paper
• Watching the clock in glioblastoma

  2023cites this paper
• macroH2A2 antagonizes epigenetic programs of stemness in glioblastoma

  2023cites this paper
• Identification of WD-Repeat Protein 72 as a Novel Prognostic Biomarker in Non-Small-Cell Lung Cancer

  2023cites this paper
• Soluble Guanylate Cyclase β1 Subunit Represses Human Glioblastoma Growth

  2023cites this paper
• New Biomarkers Based on Dendritic Cells for Breast Cancer Treatment and Prognosis Diagnosis

  2023cites this paper
• Circadian regulator CLOCK promotes tumor angiogenesis in glioblastoma

  2023cites this paper
• Identification of glioblastoma stem cell-associated lncRNAs using single-cell RNA-sequencing datasets

  2023cites this paper
• Zika virus cleaves GSDMD to disseminate prognosticable and controllable oncolysis in a human glioblastoma cell model

  2023cites this paper
• The complex network of transcription factors, immune checkpoint inhibitors and stemness features in colorectal cancer: A recent update.

  2023cites this paper
• Cancer Therapy and

  2023cites this paper
• NIR Drives Glioblastoma Growth by Promoting Ribosomal DNA Transcription in Glioma Stem Cells.

  2022cites this paper
• Updates of Role of Stem Cells in Cancer Therapy

  2022cites this paper
• Mitophagy bridges DNA sensing with metabolic adaption to expand lung cancer stem‐like cells

  2022cites this paper
• Hyaluronan Receptors as Mediators and Modulators of the Tumor Microenvironment

  2022cites this paper
• Oncolytic Zika Virus: New Option for Glioblastoma Treatment

  2022cites this paper
• Immunotherapeutic Implications of Toll-like Receptors Activation in Tumor Microenvironment

  2022cites this paper
• Cancer stem cells in immunoregulation and bypassing anti-checkpoint therapy.

  2022cites this paper
• Pediatric glioblastoma: mechanisms of immune evasion and potential therapeutic opportunities

  2022cites this paper
• GATA2-Mediated Transcriptional Activation of Notch3 Promotes Pancreatic Cancer Liver Metastasis

  2022cites this paper
• Digital Digital Defining phenotypic and functional heterogeneity of glioblastoma Defining phenotypic and functional heterogeneity of glioblastoma stem cells by mass cytometry stem cells by mass cytometry

  2022cites this paper
• Glioblastoma Embryonic-like Stem Cells Exhibit Immune-Evasive Phenotype.

  2022cites this paper
• Impact of Cancer Stem Cells and Cancer Stem Cell-Driven Drug Resiliency in Lung Tumor: Options in Sight

  2022cites this paper
• GZ17-6.02 Inhibits the Growth of EGFRvIII+ Glioblastoma

  2022cites this paper
• MD2 Is a Potential Biomarker Associated with Immune Cell Infiltration in Gliomas

  2022cites this paper
• Cancer Stem Cells in Ovarian Cancer—A Source of Tumor Success and a Challenging Target for Novel Therapies

  2022cites this paper
• Tumor Treating Fields dually activate STING and AIM2 inflammasomes to induce adjuvant immunity in glioblastoma

  2022cites this paper
• Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence

  2022cites this paper
• Specific Targeting of Cancer Stem Cells by Immunotherapy: A Possible Stratagem to Restrain Cancer Recurrence and Metastasis.

  2022cites this paper
• The multifactorial roles of microglia and macrophages in the maintenance and progression of glioblastoma.

  2021cites this paper
• Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells.

  2021cites this paper
• Defining phenotypic and functional heterogeneity of glioblastoma stem cells by mass cytometry

  2021cites this paper
• Late p65 nuclear translocation in glioblastoma cells indicates non-canonical TLR4 signaling and activation of DNA repair genes

  2021cites this paper
• Immunotherapy of Glioblastoma: Current Strategies and Challenges in Tumor Model Development

  2021cites this paper
• The DNA replication regulator MCM6: An emerging cancer biomarker and target.

  2021cites this paper
• Identification of dysregulated competing endogenous RNA networks in glioblastoma: A way toward improved therapeutic opportunities.

  2021cites this paper
• TLR4 expression and functionality are downregulated in glioblastoma cells and in tumor-associated macrophages: a new mechanism of immune evasion?

  2021cites this paper
• miR-23b-5p promotes the chemosensitivity of temozolomide via negatively regulating TLR4 in glioma.

  2021cites this paper
• Leveraging Allele-Specific Expression for Therapeutic Response Gene Discovery in Glioblastoma

  2021cites this paper
• Dual Role of Integrin Alpha-6 in Glioblastoma: Supporting Stemness in Proneural Stem-Like Cells While Inducing Radioresistance in Mesenchymal Stem-Like Cells

  2021cites this paper
• Dual Targeting of Sorafenib-Resistant HCC-Derived Cancer Stem Cells

  2021cites this paper
• Severe consequences of a high-lipid diet include hydrogen sulfide dysfunction and enhanced aggression in glioblastoma.

  2021cites this paper
• Treating ICB-resistant glioma with anti-CD40 and mitotic spindle checkpoint controller BAL101553 (lisavanbulin)

  2021influential citation
• The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure

  2021cites this paper
• Targeting the molecular mechanisms of glioma stem cell resistance to chemotherapy

  2021cites this paper
• Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas

  2021cites this paper
• Targeting PUS7 suppresses tRNA pseudouridylation and glioblastoma tumorigenesis

  2021cites this paper
• Intrinsic Interferon Signaling Regulates the Cell Death and Mesenchymal Phenotype of Glioblastoma Stem Cells

  2021cites this paper
• Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma

  2021influential citation
• Identification of biomarkers and ceRNA network in glioblastoma through bioinformatic analysis and evaluation of potential prognostic values

  2021cites this paper
• Stemness and immune evasion conferred by the TDO2‐AHR pathway are associated with liver metastasis of colon cancer

  2021cites this paper
• MR susceptibility imaging for detection of tumor-associated macrophages in glioblastoma

  2021cites this paper
• SerpinB3 drives cancer stem cell survival in glioblastoma

  2021cites this paper
• Glioblastoma Embryonic-like Stem Cells Exhibit Immune-Evasive Phenotype

  2021cites this paper
• Non-coding RNAs and glioblastoma: Insight into their roles in metastasis

  2021cites this paper
• WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastoma

  2021influential citation
• Development of arteriolar niche and self-renewal of breast cancer stem cells by lysophosphatidic Acid/protein kinase D signaling

  2021cites this paper
• Systems Of Active Immune Suppression As Integral Malignant Transformation In Infiltrating Glioma Cells

  2021cites this paper
• Epithelial-to-mesenchymal transition as the driver of changing carcinoma and glioblastoma microenvironment.

  2020cites this paper
• Bidirectional Relation Between Parkinson's Disease and Glioblastoma Multiforme

  2020cites this paper
• Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness

  2020cites this paper
• Adenovirus infection promotes the formation of glioma stem cells from glioblastoma cells through the TLR9/NEAT1/STAT3 pathway

  2020cites this paper
• The Alternative Splicing Factor, MBNL1, Inhibits Glioblastoma Tumor Initiation and Progression by Reducing Hypoxia-Induced Stemness

  2020cites this paper